Comment faire face à un événement inattendu pouvant modifier l’activité normale de thérapie cellulaire ? Recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Bay, Jacques Olivier, Beguin, Yves, Carpentier, Alexandre, Dard, Céline, Guillaume, Thierry, Labussiere-Wallet, Hélène, Lacassagne, Marie Noëlle, Sauze, Séverine, Yakoub-Agha, Ibrahim, Chalandon, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS on behalf of Société Française du Cancer. 2021
Materias:
Synthèse
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242103/
https://www.ncbi.nlm.nih.gov/pubmed/34215432
http://dx.doi.org/10.1016/j.bulcan.2021.05.002

Ejemplares similares

Ejemplares similares